Success of approved gene therapies has resulted in a surge in interest of biopharmaceutical developers in this rapidly evolving domain. Presently, the ability of gene therapies to treat diverse disease indications is considered among the most prominent drivers of this market. In addition, promising clinical results of pipeline candidates are anticipated to draw in more investments to support product development initiatives.

 

To order this 720+ page report, which features 220+ figures and 375+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/gene-therapies-market/268.html

 

The USD 14.6 billion (by 2030) financial opportunity within the gene therapy market has been analyzed across the following segments:

Therapeutic approach

Gene augmentationOncolytic therapyImmunotherapyOthers

Type of gene therapy

Ex vivoIn vivoType of vector usedAdeno associated virusAdenovirusHerpes simplex virusLentivirusPlasmid DNARetrovirusOthers

Key therapeutic areas

Autoimmune disorders

Cardiovascular diseases

Dermatological disorders

Genetic disorders

Hematological disorders

Metabolic disorders

Muscle-related diseases

Oncological disorders

Ophthalmic diseases

Others

Route of administration

IntraarticularIntracerebellarIntradermalIntramuscularIntratumoralIntravenousIntravesicalIntravitrealSubretinalOthers

Key geographical regions

North America

Europe

Asia-Pacific

 

The Gene Therapy Market (4th Edition), 2020-2030 report features the following companies, which we identified to be key players in this domain: 

Abeona TherapeuticsAdvantageneBiogenbluebird bioCastle Creek BiosciencesCG OncologyFerGeneFreeline TherapeuticsGradalisHelixmithInovio PharmaceuticalsKolon TissueGeneKrystal BiotechLysogeneNeurophth TherapeuticsOncoSec ImmunotherapiesOrchard TherapeuticsPfizerSangamo TherapeuticsSpark TherapeuticsuniQure Biopharma

VBL Therapeutics

 

Table of Contents

 

1. Preface

2. Executive Summary

3. Introduction

4. Gene Delivery Vectors

5. Regulatory Landscape and Reimbursement Scenario

6. Market Overview

7. Competitive Landscape

8. Marketed Gene Therapies

9. Key Commercialization Strategies

10. Late Stage (Phase II/III and Above) Gene Therapies

11. Emerging Technologies

12. Key Therapeutics Areas

13. Patent Analysis

14. Mergers and Acquisitions

15. Funding and Investment Analysis

16. Clinical Trial Analysis

17. Cost Price Analysis

18. Big Pharma Players: Analysis of Gene Therapy Related Initiatives

19. Demand Analysis

20. Market Forecast and Opportunity Analysis

 

21. Vector Manufacturing

 

22. Case Study: Gene Therapy Supply Chain

 

23. Conclusion

 

24. Interview Transcripts

 

25. Appendix 1: Tabulated Data

 

26. Appendix 2: List of Companies and Organizations

 

To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/gene-therapies-market/268.html

 

Contact Details

Gaurav Chaudhary

+1 (415) 800 3415

gaurav.chaudhary@rootsanalysis.com